8E8Y
 
 | 9H2 Fab-Sabin poliovirus 2 complex | Descriptor: | 9H2 Fab heavy chain, 9H2 Fab light chain, Capsid protein VP1, ... | Authors: | Charnesky, A.J. | Deposit date: | 2022-08-26 | Release date: | 2023-06-21 | Last modified: | 2025-05-21 | Method: | ELECTRON MICROSCOPY (2.5 Å) | Cite: | A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes. Nat Commun, 14, 2023
|
|
8E8Z
 
 | 9H2 Fab-Sabin poliovirus 1 complex | Descriptor: | 9H2 Fab heavy chain, 9H2 Fab light chain, Capsid protein VP1, ... | Authors: | Charnesky, A.J. | Deposit date: | 2022-08-26 | Release date: | 2023-06-21 | Last modified: | 2025-05-21 | Method: | ELECTRON MICROSCOPY (3.15 Å) | Cite: | A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes. Nat Commun, 14, 2023
|
|
8E8X
 
 | 9H2 Fab-Sabin poliovirus 3 complex | Descriptor: | 9H2 Fab heavy chain, 9H2 Fab light chain, Capsid protein VP1, ... | Authors: | Charnesky, A.J. | Deposit date: | 2022-08-26 | Release date: | 2023-06-21 | Last modified: | 2025-06-04 | Method: | ELECTRON MICROSCOPY (2.91 Å) | Cite: | A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes. Nat Commun, 14, 2023
|
|
8E8S
 
 | 9H2 Fab-poliovirus 2 complex | Descriptor: | 9H2 Fab heavy chain, 9H2 Fab light chain, Capsid protein VP1, ... | Authors: | Charnesky, A.J. | Deposit date: | 2022-08-25 | Release date: | 2023-06-21 | Last modified: | 2025-05-21 | Method: | ELECTRON MICROSCOPY (2.73 Å) | Cite: | A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes. Nat Commun, 14, 2023
|
|
8E8L
 
 | 9H2 Fab-poliovirus 1 complex | Descriptor: | 9H2 Fab heavy chain, 9H2 Fab light chain, Capsid protein VP1, ... | Authors: | Charnesky, A.J. | Deposit date: | 2022-08-25 | Release date: | 2023-06-21 | Last modified: | 2025-05-14 | Method: | ELECTRON MICROSCOPY (3.13 Å) | Cite: | A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes. Nat Commun, 14, 2023
|
|
1JEW
 
 | |
7M3L
 
 | |
7M3N
 
 | |
7M3M
 
 | |
7M3O
 
 | |
7KZF
 
 | |
6UH7
 
 | EV-A71 strain 11316 complexed with MADAL compound 30 | Descriptor: | SPHINGOSINE, VP1, VP2, ... | Authors: | Lee, H, Hafenstein, S. | Deposit date: | 2019-09-26 | Release date: | 2019-12-18 | Last modified: | 2024-03-20 | Method: | ELECTRON MICROSCOPY (2.87 Å) | Cite: | Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors. J.Med.Chem., 63, 2020
|
|
6UH6
 
 | EV-A71 strain 11316 complexed with MADAL compound 22 | Descriptor: | SPHINGOSINE, VP1, VP2, ... | Authors: | Lee, H, Hafenstein, S. | Deposit date: | 2019-09-26 | Release date: | 2019-12-18 | Last modified: | 2024-03-20 | Method: | ELECTRON MICROSCOPY (2.98 Å) | Cite: | Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors. J.Med.Chem., 63, 2020
|
|
6UH1
 
 | Structure of the EVA71 strain 11316 capsid | Descriptor: | SPHINGOSINE, VP1, VP2, ... | Authors: | Lee, H, Hafenstein, S. | Deposit date: | 2019-09-26 | Release date: | 2019-12-18 | Last modified: | 2024-03-20 | Method: | ELECTRON MICROSCOPY (3.04 Å) | Cite: | Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors. J.Med.Chem., 63, 2020
|
|
9D7K
 
 | Infectious B19V capsid | Descriptor: | Alpha-1-antichymotrypsin | Authors: | Lee, H, Hafenstein, S. | Deposit date: | 2024-08-16 | Release date: | 2024-10-16 | Last modified: | 2025-05-14 | Method: | ELECTRON MICROSCOPY (3 Å) | Cite: | Infectious parvovirus B19 circulates in the blood coated with active host protease inhibitors. Nat Commun, 15, 2024
|
|
9C4N
 
 | Infectious B19V capsid | Descriptor: | Inter-alpha-trypsin inhibitor heavy chain H4 | Authors: | Lee, H, Hafenstein, S. | Deposit date: | 2024-06-04 | Release date: | 2024-11-13 | Method: | ELECTRON MICROSCOPY (2.9 Å) | Cite: | Infectious parvovirus B19 circulates in the blood coated with active host protease inhibitors. Nat Commun, 15, 2024
|
|
9C27
 
 | Infectious B19V capsid | Descriptor: | Capsid protein 2 | Authors: | Lee, H, Hafenstein, S. | Deposit date: | 2024-05-30 | Release date: | 2024-10-16 | Last modified: | 2025-05-21 | Method: | ELECTRON MICROSCOPY (2.2 Å) | Cite: | Infectious parvovirus B19 circulates in the blood coated with active host protease inhibitors. Nat Commun, 15, 2024
|
|
9C4F
 
 | Infectious B19V capsid | Descriptor: | Capsid protein 2, Inter-alpha-trypsin inhibitor heavy chain H4 | Authors: | Lee, H, Hafenstein, S. | Deposit date: | 2024-06-04 | Release date: | 2024-10-16 | Last modified: | 2024-11-13 | Method: | ELECTRON MICROSCOPY (3.2 Å) | Cite: | Infectious parvovirus B19 circulates in the blood coated with active host protease inhibitors. Nat Commun, 15, 2024
|
|
9C2T
 
 | Infectious B19V capsid | Descriptor: | Alpha-1-antichymotrypsin His-Pro-less, Capsid protein 2 | Authors: | Lee, H, Hafenstein, S. | Deposit date: | 2024-05-31 | Release date: | 2024-10-16 | Last modified: | 2025-06-04 | Method: | ELECTRON MICROSCOPY (3.1 Å) | Cite: | Infectious parvovirus B19 circulates in the blood coated with active host protease inhibitors. Nat Commun, 15, 2024
|
|
1D3I
 
 | |
1D3E
 
 | |
1D3L
 
 | |
7JYI
 
 | Subparticle Map of ZIKV MR-766 | Descriptor: | E Glycoprotein, M protein | Authors: | Jose, J, Hafenstein, S. | Deposit date: | 2020-08-30 | Release date: | 2020-09-16 | Last modified: | 2025-05-28 | Method: | ELECTRON MICROSCOPY (3.4 Å) | Cite: | Identification of a pocket factor that is critical to Zika virus assembly. Nat Commun, 11, 2020
|
|